Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice.
about
Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out micePhospholipid transfer protein is expressed in cerebrovascular endothelial cells and involved in high density lipoprotein biogenesis and remodeling at the blood-brain barrierEvaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteinsOSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism.High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudyElevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis.Impact of phospholipid transfer protein on nascent high-density lipoprotein formation and remodeling.Isolation and partial characterization of the inactive and active forms of human plasma phospholipid transfer protein (PLTP).Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice.Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL.Osbpl8 deficiency in mouse causes an elevation of high-density lipoproteins and gender-specific alterations of lipid metabolismPlasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: a mutation-inactivation study.Liver-specific phospholipid transfer protein deficiency reduces high-density lipoprotein and non-high-density lipoprotein production in mice.The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesionsEndothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice.Adipocyte phospholipid transfer protein and lipoprotein metabolism.Reverse cholesterol transport: high-density lipoprotein's magnificent mile.Linkage and association of phospholipid transfer protein activity to LASS4Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.Functional expression of endothelial nitric oxide synthase fused to green fluorescent protein in transgenic mice.Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol levelExacerbated neuronal ceroid lipofuscinosis phenotype in Cln1/5 double-knockout mice.Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart StudyLocal and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis.Chlamydial and periodontal pathogens induce hepatic inflammation and fatty acid imbalance in apolipoprotein E-deficient mice.ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer.Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor.Plasma PLTP activity is inversely associated with HDL-C levels.High density lipoprotein particle size in children: relation to atherogenic dyslipidemia.Role of phospholipid transfer protein in high-density lipoprotein- mediated reverse cholesterol transport.The impact of phospholipid transfer protein (PLTP) on lipoprotein metabolism.Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport.HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles.Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport.Role of phospholipid transfer protein and prebeta-high density lipoproteins in maintaining cholesterol efflux from Fu5AH cells to plasma from insulin-resistant subjects.Spontaneous remodeling of HDL particles at acidic pH enhances their capacity to induce cholesterol efflux from human macrophage foam cellsMast cells promote atherosclerosis by inducing both an atherogenic lipid profile and vascular inflammation.Murine cathepsin D deficiency is associated with dysmyelination/myelin disruption and accumulation of cholesteryl esters in the brain.Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport.
P2860
Q24300591-3DA2294D-8908-4997-9610-47919AEA2AD9Q24316276-86DE7FE5-682C-4798-BC37-65042934D4C1Q24533539-8015E49F-867F-4346-B1D0-81850B7E5426Q24650988-080FC4D3-936A-4FA0-957A-956DD5F020F4Q28476672-D1A08BEF-BFF5-4E87-8AC9-E55CF1FCEB11Q33338480-14ED3BDA-A491-42C3-BCED-A2332A0F9317Q34076399-35CEE47D-C237-4FBC-91B4-E3A88EDBCC2AQ34114968-4A8512F2-EAD1-469C-8DD1-4E602E8047B5Q34155049-4FDEAF5D-88F7-4B5B-98BE-A0FAB4934A9CQ34590666-401A775E-0C5E-4315-A499-796979E876F3Q34610302-E89F5C3E-157C-4C20-9FE6-13BA2F3FD77EQ34648407-B51BAFC3-8D03-4D70-BBF0-101D9A967708Q34656954-71397D90-09A1-4AFC-B765-6F874FE5F51BQ34680124-CE10291E-9BAE-40A5-87EE-0985C7018688Q34740387-2466DBAC-9245-48D0-9F07-FE5A9476B4DCQ34961540-EE2E5DB5-A267-4D79-BAF0-B7E694D96BBBQ35007458-018D0C6B-8E19-4AA8-AA69-7F711A8E5B5EQ35197123-4F3E52E8-312F-4E5F-9B14-017884C65997Q35212888-5ECCC118-64C5-49A7-A936-E4119C28B64BQ35341853-995D6AEF-AC12-4515-B9E9-BF12068EA58EQ35792234-BC4860DF-61A3-4B09-BC71-910F76BBB953Q36282932-7F9D772F-FCF5-4B73-89E0-DC07F6E6C366Q36683039-4D58FDF8-0D0A-4CC2-8765-271701DDEA48Q36953767-BBE2AEC5-8450-4399-AB13-574377522C5AQ37075460-7237C959-69DC-4982-B130-7B6F68E4B31EQ37274899-E0582092-3264-405F-956E-15F00D19B370Q37390177-2A1E0DE5-19C0-43F0-93AC-C3034BFF1D62Q37469242-EE8E65DD-AB8F-409D-BE61-11A15670E711Q37475203-799FC2D3-6145-452A-A5FC-0D311F266D7EQ37732834-C7F18C90-8B18-40C7-8522-963CC90C296FQ37848709-ABAAC687-C0A9-432E-B929-102B4E7C2CD8Q38035073-DC7B0C9B-A593-4D19-B0D4-B395CCA2F6B2Q39141274-49068F82-A943-4488-AD3A-B32660AA2275Q39979442-F0653A3B-59A7-48A9-8756-BBB9F2B39AF7Q40358644-5004D052-E483-42DD-81B1-8A7A3E887997Q40813058-ABC50F50-C324-4F88-A624-7CB37D1407B9Q41879020-B4CF8567-9F9C-409F-8668-07F724265007Q43213347-F35E55A4-A028-4758-8B11-21466C152FB3Q43257485-690C0470-6E4E-417D-BD18-2841D7568D02Q43687486-254CB1C6-E2F4-4A79-A6F8-137A8C0CFE80
P2860
Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Human plasma phospholipid tran ...... poproteins in transgenic mice.
@en
Human plasma phospholipid tran ...... poproteins in transgenic mice.
@nl
type
label
Human plasma phospholipid tran ...... poproteins in transgenic mice.
@en
Human plasma phospholipid tran ...... poproteins in transgenic mice.
@nl
prefLabel
Human plasma phospholipid tran ...... poproteins in transgenic mice.
@en
Human plasma phospholipid tran ...... poproteins in transgenic mice.
@nl
P2093
P356
P1476
Human plasma phospholipid tran ...... poproteins in transgenic mice.
@en
P2093
Grosveld F
Jauhiainen M
Vermeulen P
van Gent T
van Haperen R
van den Berg P
van der Kamp A
P304
P356
10.1161/01.ATV.20.4.1082
P407
P577
2000-04-01T00:00:00Z